Analysis of clonality and antibiotic resistance among early clinical isolates of enterococcus faecium in the United States

Journal of Infectious Diseases

Volumn 200, Issue 10, 2009, Pages 1566-1573

  Galloway Peña, Jessica R ^a,b,c   Nallapareddy, Sreedhar R ^a,b   Arias, Cesar A ^a,b,e   Eliopoulos, George M ^c,d   Murray, Barbara E ^a,b,c  

^a Division of Infectious Diseases   (United States)

^b Center for the Study of Emerging and Reemerging Pathogens   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; ESP EFM GENE; FMS GENE; GENE; GEOGRAPHICAL VARIATION (SPECIES); HYL EFMP GENE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; VIRULENCE; BACTERIUM IDENTIFICATION; CROSS INFECTION; DNA SEQUENCE; DRUG EFFECT; GENETICS; GRAM POSITIVE INFECTION; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE;

AMPICILLIN RESISTANCE; BACTERIAL TYPING TECHNIQUES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA; UNITED STATES; VANCOMYCIN; VIRULENCE;

EID: 70449721887     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/644790     Document Type: Article

References (51)

1. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994; 7:462-478
2. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3:46-65.
3. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011
4. (erratum: Infect Control Hosp Epidemiol 2009; 30:107).
5. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9:454-460
6. Turner KM, Hanage WP, Fraser C, Connor TR, Spratt BG. Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol 2007; 7:30. (Pubitemid 46931739) (Pubitemid 46931739)
7. eBURSTv3. Available at: http://eburst.mlst.net. Accessed 2 October 2009.
8. Rice LB, Carias L, Rudin S, et al. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 2003; 187:508-512
9. Leavis H, Top J, Shankar N, et al. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 2004; 186:672-682
10. Willems RJ, Homan W, Top J, et al. Variant esp gene as a marker ofa distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 2001; 357:853-855
11. Hendrickx AP, van Wamel WJ, Posthuma G, Bonten MJ, Willems RJ. Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J Bacteriol 2007; 189:8321-8332
12. Sillanpãã J, Nallapareddy SR, Prakash VP, et al. Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology 2008; 154:3199-3211
13. Sillanpãã J, Prakash VP, Nallapareddy SR, Murray BE. Distribution of genes encoding MSCRAMMs and pili in clinical and natural populations of Enterococcus faecium. J Clin Microbiol 2009; 47:896-901.
14. Hendrickx AP, Bonten MJ, van Luit-Asbroek M, Schapendonk CM, Kragten AH, Willems RJ. Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. Microbiology 2008; 154: 3212-3223
15. Nallapareddy SR, Singh KV, Sillanpãã J, et al. Endocarditis and biofilmassociated pili of Enterococcus faecalis. J Clin Invest 2006; 116:2799-2807
16. Lester CH, Sandvang D, Olsen SS, et al. Emergence of ampicillinresistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother 2008; 62:1203-1206
17. Willems RJ, Top J, van Santen M, et al. Global spread of vancomycinresistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11:821-828
18. 17. Bush LM, Calmon J, Cherney CL, et al. High-level penicillin resistance among isolates of enterococci: implications for treatment of enterococcal infections. Ann Intern Med 1989; 110:515-520 (Pubitemid 19097319)
19. Coudron PE, Mayhall CG, Facklam RR, et al. Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol 1984; 20: 1044-1048
20. Sapico FL, Canawati HN, Ginunas VJ, et al. Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol 1989; 27:2091-2095
21. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33:24-27 (Pubitemid 24382391)
22. Eliopoulos GM,Wennersten C, Zighelboim-Daum S, Reiszner E, Goldmann D, Moellering RC Jr. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 1988; 32:1528-1532
23. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16:750-755
24. Grayson ML, Eliopoulos GM, Wennersten CB, et al. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991; 35:2180-2184
25. Miranda AG, Singh KV, Murray BE. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991; 29:2752-2757
26. Stratton CW, Liu C, Ratner HB, Weeks LS. Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by killkinetic studies. Antimicrob Agents Chemother 1987; 31:1014-1016 (Pubitemid 17099570) (Pubitemid 17099570)
27. Spiegel CA. Laboratory detection of high-level aminoglycoside- aminocyclitol resistance in Enterococcus spp. J Clin Microbiol 1988; 26: 2270-2274
28. Boyce JM, Opal SM, Potter-Bynoe G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992; 36:1032-1039
29. Singh KV, Coque TM, Murray BE. In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms. Antimicrob Agents Chemother 1996; 40:2142-2146
30. Korten V, Huang WM, Murray BE. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother 1994; 38: 2091-2094 (Pubitemid 24278806)
31. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996; 40:2605-2609
32. Homan WL, Tribe D, Poznanski S, et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40:1963-1971
33. Multi Locus Sequence Typing. Available at: http://efaecium.mlst.net. Accessed 21 September 2009.
34. Nallapareddy SR, Singh KV, Okhuysen PC, Murray BE. A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect Immun 2008; 76:4110-4119
35. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.
36. Singh KV, Coque TM, Weinstock GM, Murray BE. In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol Med Microbiol 1998; 21:323-331
37. Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther 2008; 6:637-655
38. Eliopoulos GM, Wennersten C, Moellering RC Jr. Resistance to βlactam antibiotics in Streptococcus faecium: Antimicrob Agents Chemother 1982; 22:295-301.
39. Poeta P, Costa D, Igrejas G, et al. Polymorphisms of the pbp5 gene and correlation with ampicillin resistance in Enterococcus faecium isolates of animal origin. J Med Microbiol 2007; 56:236-240
40. Rice LB, Bellais S, Carias LL, et al. Impact of specific pbp5 mutations on expression of β-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004; 48:3028-3032
41. Rice LB, Carias LL, Rudin S, Lakticova V, Wood A, Hutton-Thomas R. Enterococcus faecium low-affinity pbp5 is a transferable determinant. Antimicrob Agents Chemother 2005; 49:5007-5012
42. Top J, Willems R, Bonten M. Emergence of CC17Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 2008; 52:297-308.
43. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157-161
44. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1:57-58
45. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32:1148-1153
46. Donskey CJ, Schreiber JR, Jacobs MR, et al. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis 1999; 29:573-579
47. Handwerger S, Perlman DC, Altarac D, McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992; 14:655-661
48. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistantEnterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995; 21:1234-1237
49. Heikens E, Bonten MJ, Willems RJ. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 2007; 189:8233-8240
50. Rice LB, Lakticová V, Carias LL, Rudin S, Hutton R, Marshall SH. Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model. J Infect Dis 2009; 199:342-349
51. Arias CA, Panesso D, Singh KV, Rice LB, Murray BE. Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium. Antimicrob Agents Chemother 2009; 53: 4240-4246